HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of propafenone in congenital junctional ectopic tachycardia.

AbstractOBJECTIVES:
Class IC antiarrhythmic drugs have recently been shown to be effective in some patients with atrial ectopic tachycardia. We therefore studied the efficacy of these drugs in patients with congenital junctional ectopic tachycardia.
BACKGROUND:
Follow-up data on patients with junctional ectopic tachycardia suggest that this potentially lethal arrhythmia may cease spontaneously in a significant proportion of affected children. Therefore, temporary antiarrhythmic treatment appears to be the therapy of choice.
METHODS:
The efficacy of propafenone was prospectively assessed in four infants with junctional ectopic tachycardia (ventricular rate 180, 185, 210 and 320 beats/min, respectively). The diagnosis of junctional ectopic tachycardia was established before the age of 2 months in all four infants. Propafenone was given orally in a mean dose of 350 (300 to 500) mg/m2 body surface area per day. Success of therapy was determined by serial electrocardiograms (ECGs) and Holter ambulatory ECG monitoring.
RESULTS:
In two patients, junctional ectopic tachycardia was completely suppressed. In the remaining two patients, the tachycardia rate decreased to less than 150 beats/min. Serum propafenone levels did not correlate with efficacy of treatment. The mean duration of therapy was 18 months (range 3 to 36). No chemical or clinical side effects were noted.
CONCLUSIONS:
Because of its effectiveness, safety and lack of side effects, propafenone appears to be a valuable drug in the treatment of junctional ectopic tachycardia in newborns and infants.
AuthorsT Paul, A Reimer, J Janousek, H C Kallfelz
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 20 Issue 4 Pg. 911-4 (Oct 1992) ISSN: 0735-1097 [Print] United States
PMID1527301 (Publication Type: Case Reports, Clinical Trial, Journal Article)
Chemical References
  • Propafenone
Topics
  • Drug Evaluation
  • Electrocardiography (methods)
  • Electrocardiography, Ambulatory
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Propafenone (administration & dosage, therapeutic use)
  • Prospective Studies
  • Tachycardia, Ectopic Junctional (congenital, drug therapy, epidemiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: